Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Health

Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

F&P Healthcare: don’t mention the tariffs!
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
Record half for F&P Healthcare
Markets

Record half for F&P Healthcare

A strong result boosts dividend, suspends dividend reinvestment scheme.

Pattrick Smellie 28 Nov 2024
Nanogirl liquidates Lab
Health

Nanogirl liquidates Lab

Nanogirl Labs liquidated as funding cuts hit STEM education.

Garth Bray 28 Nov 2024